AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals |
| March 04, 2019 | March 2019 Bond Updates |
|
TOKYO, March 4, 2019 /PRNewswire/ -- AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC). The transaction had been previously... |
| View more at: https://www.prnewswire.com:443/news-releases/agc-completes-acquisition-of-spanish-synthetic-pharmaceutical-active-ingredient-manufacturer-malgrat-pharma-chemicals-300805594.html |
| Related News |